ENTITY
Hugel Inc

Hugel Inc (145020 KS)

51
Analysis
Health CareSouth Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
bearishHugel Inc
15 Aug 2021 05:44

The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?

The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.

Logo
422 Views
Share
bearishHugel Inc
29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
329 Views
Share
28 Mar 2019 07:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
09 May 2018 11:46

Sejong Medical IPO Preview (Part 2) - Valuation Analysis

Sejong Medical Comparable Companies Valuation AnalysisWe are negative on the Sejong Medical IPO. The four major comps that the bankers used for...

Logo
195 Views
Share
20 Apr 2018 23:00

Sejong Medical IPO Preview (Part 1)

Sejong Medical Co Ltd (258830 KS) is an IPO in Korea that is expected to be completed in May 2018. Sejong Medical is a medical device maker in...

Logo
240 Views
Share
x